OTC Markets EXMKT - Delayed Quote USD
GeneLink, Inc. (GNLKQ)
At close: October 30 at 4:00 PM EDT
Key Executives
Amounts are as of December 31, 2008 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Bernard L. Kasten Jr., Ph.D., M.D. | Executive Chairman, Chief Executive Officer, President and Member of Scientific Advisory Board | 23.72k | -- | 1946 |
| Dr. Robert P. Ricciardi | Founder, Chief Science Officer, Treasurer, Secretary, Director & Member of Scientific Advisory Board | 30k | -- | 1947 |
| Mr. Michael G. Smith | COO & Interim CFO | -- | -- | 1966 |
GeneLink, Inc.
8240 Exchange Drive
Suite C1
Orlando, FL 32809
United States
- Sector:?
- Healthcare
- Industry:? Biotechnology
Description
GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.
Corporate Governance
GeneLink, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available